eTheRNA Manufacturing, a specialist CDMO member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and ...
The study evaluates how omega-3 delivery architecture influences triglyceride outcomes and omega-3 incorporation in ...
In this whitepaper, Gattefossé Pharmaceuticals seeks to bridge the gap between lipid-based formulations and oral solid dosage ...
CannaLean Biotechs Ltd., a clinical-stage biotechnology company developing a patented cannabidiol–chitosan (CBD–CHT) formulation for dyslipidemia, today announced the successful completion of its ...
BOSTON--(BUSINESS WIRE)--Quolet, a private clinical stage biopharmaceutical company, is announcing the completion of a Phase 1 healthy volunteer study evaluating pure Cannabidiol (CBD) (clinicaltrials ...
Researchers at Entos Pharmaceuticals report today in Cell that they have developed a particle that can deliver DNA and RNA to many tissues without triggering an immune response (2024, DOI: ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The study included 14 healthy individuals who were given ...
Researchers at Nagoya University in Japan have developed a lipid nanoparticle that delivers mRNA to cells five times more effectively. By attaching a sulfur-containing ring structure—a cyclic ...
Cholesterol is a type of fat that helps the human body make cell membranes, hormones, and vitamin D. The recommended total limit of cholesterol is 200mg/dL, with HDL (“good” cholesterol) being above ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results